Hernandez-Davies, J. E., Zape, J. P., Landaw, E. M., Tan, X., Presnell, A., Griffith, D., . . . Sakamoto, K. M. (2011). The multi-targeted receptor tyrosine kinase inhibitor, Linifanib (ABT-869), induces apoptosis through an AKT and Glycogen Synthase Kinase 3β-dependent pathway.

Hernandez-Davies, Jenny E., Joan P. Zape, Elliot M. Landaw, Xiaolin Tan, Ajia Presnell, Diana Griffith, Michael C. Heinrich, Keith B. Glaser, and Kathleen M. Sakamoto. The Multi-targeted Receptor Tyrosine Kinase Inhibitor, Linifanib (ABT-869), Induces Apoptosis Through an AKT and Glycogen Synthase Kinase 3β-dependent Pathway. 2011.

Hernandez-Davies, Jenny E., et al. The Multi-targeted Receptor Tyrosine Kinase Inhibitor, Linifanib (ABT-869), Induces Apoptosis Through an AKT and Glycogen Synthase Kinase 3β-dependent Pathway. 2011.